Thyroid Tablets
Superpotent Drug
Class I — High risk. Reasonable probability of serious harm or death.
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Cause type: Packaging defect
Failed child-resistant closures, leaks, cracked containers, or a defective delivery device. Packaging failures risk accidental exposure (especially to children) or product contamination. All packaging defect recalls.
Natpara (parathyroid hormone) for Injection, 75 mcg, 2 pack medication cartridges, Rx only, For subcutaneous use only, Manufactured for: Shire-NPS Pharmaceuticals, Inc., Lexington, MA NDC 68875-0204-02
Compare with the code on your package — it is the most precise check available.
Drug: Thyroid
Treat this as urgent. Class I means FDA judged there is a reasonable probability of serious harm. Find the lot number on your package; if it matches the recalled lots, do not take another dose before you have spoken to your pharmacist or prescriber - today, not next week. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.
Superpotent Drug
Subpotent Drug
Failed Stability Specifications
Failed Stability Specifications
Lack of sterility assurance
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Defective Delivery System: potential risk of rubber stopper particles clogging the needle and leading to underdosing
Presence of Particulate Matter; Particulates identified as stainless steel and barium sulfate.
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.